Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00808912 · ClinicalTrials.gov registry record · NA
Does Sildenafil Increase Exercise Performance in Air Pollution?
A NA study of Pulmonary Hypertension and Air Pollution, sponsored by Marywood University.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT00808912: Completed NA study of Pulmonary Hypertension and Air Pollution, sponsored by Marywood University.
NCT00808912 is a NA study of Pulmonary Hypertension and Air Pollution that has completed, run by Marywood University. The registered enrollment target is 24 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00808912, a NA study of Pulmonary Hypertension and Air Pollution, has completed, sponsored by Marywood University.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine if the ingestion of a standard dose of sildenafil enhances the athletic performance of competitive athletes when exercising in a high pollutant environment verses a low air pollutant environment.
Conditions Studied
Interventions
- OTHER placebo
- DRUG sildenafil
Study Locations (1)
Pennsylvania
- Marywood University - Scranton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-12 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00808912 record still lists
NCT00808912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (96% lower).
The record links to 4 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00808912 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00808912 about?
NCT00808912 is a clinical study titled "Does Sildenafil Increase Exercise Performance in Air Pollution?". The purpose of this study is to examine if the ingestion of a standard dose of sildenafil enhances the athletic performance of competitive athletes when exercising in a high pollutant environment verses a low air pollutant environment.
What is the current status of trial NCT00808912?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2008-12. Estimated completion is 2010-02.
What conditions does trial NCT00808912 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Air Pollution, Exercise Performance, Pulmonary Artery Pressure.
What interventions are being tested in trial NCT00808912?
The interventions under investigation include: placebo (OTHER), sildenafil (DRUG).
Who is sponsoring clinical trial NCT00808912?
This trial is sponsored by Marywood University, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00808912 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00808912's enrollment target sits among peer trials
24 54th of 72 higher than 17 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
-
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
RECRUITING · NA
-
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
RECRUITING · NA
-
Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia